Ebola Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure
Condition:   Healthy VolunteersIntervention:   Drug: rVSVdeltaG-ZEBOV GP (2X 107 pfu/mL)Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 28, 2016 Category: Research Source Type: clinical trials